Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_639_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
62 Мб
Скачать
192 Part II Abdominal Wall
the abdominal wall. e ureteral anastomoses are performed, and stents are placed (Fig. 9-17E). All aspects of the stoma construction are the same as those for an ileostomy except that the appliance must contain a valve to allow emptying since the volume of urine is high and its weight may tend to pull the appliance o. is problem is avoided by the patient emp­tying the appliance frequently and by sleeping attached to a night drainage system.
Complications of the Urinary Conduit
e most common complication of a urinary conduit is a leaking appliance because of improper placement or construc­tion of a ush rather than a protruding stoma. Although some urologists believe that a ush stoma is less susceptible to injury, most surgeons disagree with this concept and believe that a spigot conguration is best. Sometimes sutures are placed in the skin rather than in the dermis during stoma construction. is leads to a circumferential series of radial scars that pre­clude maintenance of the seal of the appliance. Because the stoma euent is thin liquid, the appliance seal must be precise to avoid injury to the peristomal skin. If there is stasis in the conduit, an odor will develop and become the cause of great concern to the patient. Odor, increased mucus production, ank pain, and fever can indicate a urinary tract infection. In order to obtain an accurate urine sample for culture, it is necessary to intubate the stoma rather than sending urine col­lected from the appliance. It is not unusual to have to revise and sometimes relocate ush urinary conduit stomas. If this is done, care must be taken to ensure that the length of the conduit is adequate. If it is not, it is possible to add a segment of small intestine so that a proper stoma can be constructed without having to revise the ureterointestinal anastomoses.
e patient who does not maintain adequate personal hygiene and acidication of the urine may develop stone for­mation, with crystal formation around the stoma itself. is development can be alleviated by acidifying the urine or by cleaning and soaking the pouch with white vinegar. e use of Collyseal (Torbot Co.) can also be used to maintain an acidic environment and thus minimize crystal formation at the stoma. If the stoma has been constructed within the eld of radiation, the radiation can break down the skin around the stoma. is requires relocation of the stoma to a nonirradiated location on the abdominal wall. Relocation should be done even if the upper quadrants need to be used. Recent advances have employed the principles of Kock pouch construction, previously described, to allow construction of a continent urinary diversion.
INTESTINAL FISTULA
e formation of an intestinal stula is not planned by the surgeon. erefore, it must be dealt with as it occurs. Apply­ing modern principles of stoma care to maintain the integrity of the peristomal skin until denitive treatment of the stula can be carried out should prevent damage to the skin from
primitive means of preventing severe destruction of the skin and abdominal wall. ese stomal care techniques, coupled with intravenous nutritional supplementation, should allevi­ate uncontrolled intestinal drainage from abdominal wounds.
LAPAROSCOPIC CREATION OF INTESTINAL STOMAS
e most appealing operation early on in the laparoscopic colorectal surgery experience was creation of a diverting intestinal stoma. Laparoscopic loop stoma creation does not require division of the bowel or anastomosis, and the only incision larger than 5 mm required is at the stoma site. us, the full benets of the totally laparoscopic approach can be realized. Surgeons inexperienced in lap­aroscopic approaches to colorectal disease may nd that creation of intestinal stomas is a relatively straightfor­ward and rewarding method to begin their laparoscopic colorectal experience.
Laparoscopic creation of intestinal stomas was reported in the early 1990s and the technique was quickly adopted by many surgeons. Several case series demonstrating the safety and ecacy of the procedure have been reported in the literature. Although there has not been a prospec­tive, randomized trial of laparoscopic versus open stoma creation, case-controlled series have demonstrated reduced duration of postoperative ileus and reduced length of hos­pital stay with the laparoscopic approach. e benets of the laparoscopic approach to stoma creation became immediately obvious to surgeons, and thus, it is unlikely that a prospective, randomized trial will ever be performed comparing outcomes of stomas created using laparoscopy versus laparotomy.
Laparoscopic ileostomy and colostomy creation have been performed for a plethora of indications, including obstructing rectal adenocarcinoma, rectal obstruction from extrarectal malignancies, fecal incontinence, penetrating rec­tal trauma, sacral pressure ulceration, obstructed defecation, perineal Crohn’s disease, pelvic fracture, and lumbosacral burns. Virtually any disease process that is an indication for fecal diversion is an indication for consideration of the lap­aroscopic approach. Laparoscopic creation of diverting loop colostomy is particularly appropriate for patients suering from symptomatic near-obstructing rectal carcinoma. e technique allows the surgeon to evaluate the liver and perito­neum for the presence of metastases that may be undetected on preoperative imaging studies, and institute fecal diversion without creating adhesions in the abdomen and pelvis that may increase toxicity of neoadjuvant radiotherapy and make future proctectomy more dicult. e absence of a laparo­tomy incision allows patients to recover rapidly, and allows them to begin neoadjuvant radiotherapy treatments almost immediately.
Some authors have argued that trephine stoma creation is an easier, quicker, and less expensive method of stoma cre­ation than the laparoscopic technique. For the thin patient
Chapter 9 Intestinal Stomas 193
with a virgin abdomen who will not benet from abdominal exploration, the trephine method does oer those advantages. However, for patients who are obese, those who have had multiple prior laparotomies, those who would benet from abdominal exploration, or those who require mobilization of the intestine from its retroperitoneal attachments, the laparo­scopic approach oers signicant advantages.
In order to save time and expense in the operating room, we have developed an approach to the patient requiring fecal diversion that combines the advantages of both trephine and laparoscopic stoma creation. If the patient is thin and would not necessarily benet from laparoscopic exploration of the peritoneal cavity, the patient is approached initially with the intention of creating a trephine stoma, with the laparoscopic approach held in reserve. e patient is posi­tioned for a laparoscopic procedure, but the laparoscopic equipment is kept unopened in the operating room. e stoma incision is made, and if the bowel can be delivered in correct orientation to the skin level, the stoma is created and the laparoscopic equipment remains unopened. However, if trephine creation of the stoma is impossible, a Hasson tro­car is placed through the stoma incision and the procedure proceeds laparoscopically.
Technique of Laparoscopic Stoma Creation
Patients undergoing diverting colostomy should be placed in the dorsal lithotomy or split leg position in order to have access to the anorectum; patients undergoing ileostomy may be placed in the supine position. e preselected stoma site is opened, a purse-string suture is placed in the posterior rec­tus sheath, and a Hasson trocar is placed. A 5 mm trocar is placed in the contralateral abdomen and the peritoneal cavity explored. If the bowel to be used for the stoma is suciently mobile, no other trocars need to be placed. If mobilization is required, additional 5 mm trocars can be placed to facilitate the dissection. Mobility is usually adequate when the bowel will reach to the peritoneal surface at the stoma site, as the distance to the skin level will decrease when pneumoperito­neum is released. A 5 mm camera is then placed through one of the 5 mm port sites, and the bowel grasped in the correct orientation using an instrument placed through the Hasson trocar at the stoma site. It is occasionally useful to mark the bowel for orientation of the proximal and distal limbs with sutures or clips prior to delivery through the stoma site—this is especially true when creating an ileostomy. e pneumo­peritoneum is then released and the posterior rectus sheath opened over the trocar, allowing the bowel to be delivered through the stoma opening.
If the bowel is to be divided and an end stoma fashioned, it is critical that orientation be conrmed. Left-sided colos­tomy orientation can be conrmed by insuation of air through a proctoscope, instillation of povidone iodine or dye through a small opening in the distal limb of the stoma with conrmation of dye passage to the rectum via a proctoscope,
or passage of a exible sigmoidoscope to the stoma site. Alternatively, the colon can be divided with a linear-cutting stapler, the distal end is allowed to retract into the peritoneal cavity, and direct visualization with a 5 mm laparoscope is performed to ensure that the distal bowel can be traced in continuity to the rectum.
e rapidity with which postoperative ileus resolves fol­lowing laparoscopic creation of intestinal stomas may allow patients to return home within 1–2 days. is may create a problem for the patient and the CWOCN, who has little time to perform in-hospital stoma care training. erefore, it is imperative that the patient meet with the CWOCN preop­eratively, not only for stoma site marking, but for stoma care teaching as well.
Laparoscopic Stoma Closure
Laparoscopic techniques are most applicable to patients who have undergone colectomy with construction of a proximal colostomy. Although laparoscopic adhesiolysis is occasionally a benecial adjunct to loop stoma closure, this is rarely required, as most loop stomas can be closed via a peristomal incision. e most common indication for a laparoscopic approach to the restoration of intestinal continuity is colostomy take­down and construction of coloproctostomy following sigmoid colectomy for complicated diverticular disease (“Hartmann reversal”). is procedure can either be straightforward or complicated, depending on the number and severity of intra­peritoneal adhesions and the degree of pelvic brosis.
Several methods can be used to perform laparoscopic Hartmann reversal. Some surgeons establish laparoscopic access initially, perform adhesiolysis, mobilize the colon and rectum, take down the colostomy and insert the anvil of the end-to-end stapling device, re-establish pneumoperitoneum, and perform the anastomosis. A more cost-eective method is to take down the colostomy initially, perform as much of the procedure as possible through the colostomy opening, and then decide whether a laparoscopic technique is feasible. A substantial amount of adhesiolysis and mobilization can often be performed through the stoma incision, especially if there is a parastomal hernia present that has enlarged the fascial opening. e proximal colon can be prepared for anas­tomosis and the anvil of a circular stapling device inserted. If a determination of laparoscopic feasibility can be made prior to establishing pneumoperitoneum, it avoids the need to open any laparoscopic instruments or struggle with fruitless attempts at laparoscopic dissection prior to conversion. How­ever, if it appears that laparoscopic techniques are likely to be successful, pneumoperitoneum is then established, either by closure of the fascia around a port or by insertion of a hand-assist device. e size of the fascial defect will deter­mine which method is more advantageous for the patient and surgeon. e operation is then completed laparoscopically.
Prior to embarking on a laparoscopic reversal of a Hart­mann procedure performed for diverticular disease, the sur­geon should consider that it may be necessary to resect retained
194 Part II Abdominal Wall
sigmoid colon and mobilize the splenic exure to allow soft descending colon to reach easily into the pelvis for a colorec­tal anastomosis. Preoperative evaluation of the proximal colon and distal rectal stump with endoscopy and/or contrast enema will help the surgeon plan the operative procedure and exclude alternative diagnoses.
It is also possible to perform laparoscopic restoration of intestinal continuity following total abdominal or subtotal colectomy and ileostomy. e ileostomy can be taken down, and an end-to-end anastomosis performed laparoscopically using a surgical stapling device.
SELECTED READINGS
Arumugam PJ, Bevan L, MacDonald L, et al. A prospective audit of stomas—
analysis of risk factors and complications and their management. Colorectal Dis. 2003;5:49–52.
Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin North
Am. 1950;30:1511.
Burch J. e pre- and postoperative nursing care for patients with a stoma.
Br J Nurs. 2005;14(6):310–318.
Butcher HR Jr, Sugg WL, McAfee CA, et al. Ileal conduit method of ureteral
urinary diversion. Ann Surg. 1962;156:682.
Byers JM, Steinberg JB, Postier RG. Repair of parastomal hernias using
polypropylene mesh. Arch Surg. 1992;127:1246.
Chechile G, Klein EA, Bauer L, Novick AC, Montie JE. Functional equiva-
lence of end and loop ileal conduit stomas. J Urol. 1992;147:582.
Cheung MT. Complications of an abdominal stoma: an analysis of 322 stomas.
Aust N Z J Surg. 1995;65:808–811.
Colwell J, Goldberg MT, Carmel JE. Fecal and Urinary Diversions: Manage-
ment Principles. Mosby Publishing; St. Louis, MO. 2009.
Corman JM, Odenheimer DB. Securing the loop—historic review of the methods
used for creating a loop colostomy. Dis Colon Rectum. 1991;34:1014.
Crile G Jr, Turnbull RB Jr. Mechanism and prevention of ileostomy dysfunction.
Ann Surg. 1954;140:459.
Deol ZK, Shayani V. Laparoscopic parastomal hernia repair. Arch Surg.
2003;138:203–205.
Dinnick T. e origins and evolution of colostomy. Br J Surg. 1934;22:142. Doughty D. Role of the enterostomal therapy nurse in ostomy patient
rehabilitation. Cancer. 1992;70(Suppl):1390.
Edwards DP, Leppington-Clarke A, et al. Stoma-related complications are
more frequent after transverse colostomy than loop ileostomy: a prospective randomized clinical trial. Br J Surg. 2001;88:360–363.
Feinberg SM, McLeod RS, Cohen Z. Complications of loop ileostomy. Am J
Surg. 1987;153:102.
Fleshman JW, Cohen Z, McLeod RS, Stern H, Blair J. e ileal reservoir and
ileoanal anastomosis procedure: factors aecting technical and functional outcome. Dis Colon Rectum. 1988;31:10.
Fleshman JW. Loop ileostomy. Surg Rounds. 1992;Feb:129. Fucini C, Wol BG, Dozois RR. Bleeding from peristomal varices: perspec-
tives on prevention and treatment. Dis Colon Rectum. 1991;34:1073.
Gottlieb LM, Handelsman JC. Treatment of outow tract problems associated
with continent ileostomy (Kock pouch): report of six cases. Dis Colon Rectum. 1991;34:936.
Grundfest-Broniatowski S, Fazio V. Conservative treatment of bleeding stomal
varices. Arch Surg. 1983;118:981.
Guenaga KF, Lustosa SA, Saad SS, Saconato H, Matos D. Ileostomy or co-
lostomy for temporary decompression of colorectal anastomosis. Cochrane Database Syst Rev. 2007;(1):CD004647.
Hasegawa H, Radley S, Morton DG, Keighley MR. Stapled versus su-
tured closure of loop ileostomy: a randomized controlled trial. Ann Surg. 2000;231:202–204.
Hampton B. Ostomies and Continent Diversions: Nursing Management. Mosby
Publishing; St. Louis, MO. 1992.
Huser N, Michalski CW, Erkan M. Systematic review and meta-analysis of
the role of defunctioning stoma in low rectal cancer surgery. Ann Surg. 2008;248(1):52–60.
Janes A, Cengiz Y, Israelsson LA. Preventing parastomal hernia with a pros-
thetic mesh. Arch Surg. 2004;139:1356–1358.
Jayaprakash A, Creed T, Stewart L. Should we monitor vitamin B
patients who have had end-ileostomy for inammatory bowel disease? Int J
Colorectal Dis. 2004;19:316–318. Jeter KF. Perioperative teaching and counseling. Cancer. 1992; 70 (Suppl):1346. Jeter KF. ese Special Children. A Book for Parents of Children with Colostomies,
Ileostomies, & Urostomies. Palo Alto, CA: Bull; 1982. Kalady MF, Fields RC Klein S, Nielsen KC, Mantyh, CR, Ludwig, KA. Loop
ileostomy closure at an ambulatory surgery facility: a safe and cost-eective
alternative to routine hospitalization. Dis Colon Rectum. 2003;46:486–490. Kaveggia FF, ompson JS Taylor RJ. Placement of an ileal loop urinary
diversion back in continuity with the intestinal tract. Surgery. 1991;110:557. Khoo RE, Cohen MM. Laparoscopic ileostomy and colostomy. Ann Surg.
1995;221:207–208. Kodner IJ. Colostomy and ileostomy. Clin Symp. 1978;30:1. Kodner IJ. Colostomy. Indications, techniques for construction, and management
of complications. Semin Colon Rectal Surg. 1991;2:73. Kodner IJ, Fry RD. Intestinal stomas: their management. In: Veidenheimer
MC, ed. Seminars in Colon & Rectal Surgery. Philadelphia, PA: WB Saunders;
1991:65. Kodner IJ. Stoma complications. In: Fazio VW, ed. Current erapy in Colon
and Rectal Surgery. Hamilton, Ontario: BC Decker; 1989:420. Köhler LW, Pemberton JH, Zinsmeister AR, Kelly KA. Quality of life after
proctocolectomy: a comparison of Brooke ileostomy, Kock pouch, and ileal
pouch-anal anastomosis. Gastroenterology. 1991;101:679. Leblanc KA, Bellanger DE, Whitaker JM, Hausmann MG. Laparoscopic para-
stomal hernia repair. Hernia. 2005;9:140–144. Leung TT, MacLean AR, Buie WD, Dixon E. Comparison of stapled versus hand-
sewn loop ileostomy closure: a meta-analysis. J Gastrointest Surg. 2008;12(5):
939–944. Ludwig KA, Milsom JW, Garcia-Ruiz A, Fazio VW. Laparoscopic techniques
for fecal diversion. Dis Colon Rectum. 1996;39:285–288. MacKeigan JM, Cataldo PA. Intestinal Stomas: Principles, Techniques, and
Management. St. Louis, MO: Quality Medical; 2004. MacLeod JH. Colostomy irrigation—a transatlantic controversy. Dis Colon
Rectum. 1972;15:357. Marcello PW, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Veidenheimer
MC. Obstruction after ileal pouchanal anastomosis: a preventable complica-
tion? Dis Colon Rectum. 1993;36:1105–1111. McLeod RS, Fazio VW. Quality of life with the continent ileostomy. World J
Surg. 1984;8:90. McLeod RS, Lavery IC, Leatherman JR. Patient evaluation of the conventional
ileostomy. Dis Colon Rectum. 1985;28:152. Nightingale JMD, Lennard-Jones JE, Walker ER, Farthing MJ. Oral salt supple-
ments to compensate for jejunostomy losses: comparison of sodium chloride
capsules, glucose electrolyte solution, and glucose polymer electrolyte solution.
Gut. 1992;33:759. Oliveira L, Reissman P, Nogueras J, Wexner SD. Laparoscopic creation of sto-
mas. Surg Endosc. 1997;11:19–23. Ortiz H, Sara MJ, Armendariz P, de Miguel M, Marti J, Chocarro C. Does the
frequency of paracolostomy hernias depend on the position of the colostomy
in the abdominal wall? Int J Colorectal Dis. 1994;9:65–67. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer,
with or without permanent colostomy. Cochrane Database Syst Rev. 2004;3:
CD004323 Parks SE, Hastings PR. Complications of colostomy closure. Am J Surg.
1985;149:672. Pata G, D’Hoore A, Fieuws S, Penninckx F. Mortality risk analysis following
routine vs selective defunctioning stoma formation after total mesorectal
excision for rectal cancer. Colorectal Dis. 2009;11(8):797–805. Pearl RK, Prasad ML, Orsay CP, Abcarian H, Tan AB, Melzl MT. Early local
complications from intestinal stomas. Arch Surg. 1985;120:1145. Pearl RK, Prasad ML. End-loop stomas: the new generation of intestinal sto-
mas. Contemp Surg. 1985;27:270. Pemberton JH, Philips SF, Ready RR, Zinsmeister AR, Beahrs OH. Quality of
life after Brooke ileostomy and ileal pouch-anal anastomosis: comparison of
performance status. Ann Surg. 1989;209:620. Prasad ML, Abcarian H. Pearl RK. End-loop colostomy. Surg Gynecol Obstet
1984; 158:380 Prasad ML, Pearl RK, Orsay CP, Abcarian H. Rodless ileostomy. A modied
loop ileostomy. Dis Colon Rectum. 1984;27:270.
levels in
12
Chapter 9 Intestinal Stomas 195
Price AL, Rubio PA. Laparoscopic colorectal surgery: a challenge for ET
nurses. J Wound Ostomy Continence Nurs. 1994; 21:179–182.
Read TE, Salgado J, Ferraro D, Fortunato R, Caushaj PF. “Peek port”: a novel
approach to avoid conversion in laparoscopic colectomy. Surgical Endoscopy. 2009;23(3):477–481.
Remzi FH, Oncel M, Hull TL, Strong SA, Lavery IC, Fazio VW. Current indica-
tions for blow-hole colostomy:ileostomy procedure. A single center experience. Int J Colorectal Dis. 2003;18:361–364.
Rieger N, Moore J, Hewett P, Lee S, Stephens J. Parastomal hernia repair.
Colorectal Dis. 2004;6:203–205.
Rolstad BS, Wilson G, Rothenberger DA. Sexual concerns in the patient with
an ileostomy. Dis Colon Rectum. 1983;26:170.
Rombeau JL, Wilk PJ, Turnbull RB Jr, Fazio VW. Total fecal diversion by the tem-
porary skin-level loop transverse colostomy. Dis Colon Rectum. 1978;21:223.
Rondelli F, Reboldi P, Rulli A, Matthews JB. Loop ileostomy versus loop co-
lostomy for fecal diversion after colorectal or coloanal anastomosis: a meta­analysis. Int J Colorectal Dis. 2009;24(5):479–488.
Rubin MS, Schoetz DJ Jr, Matthews B. Parastomal hernia. Is stoma relocation
superior to fascial repair? Arch Surg. 1994;129:413–418.
Saha AK, Tapping CR, Foley GT, et al. Morbidity and mortality after closure of
loop ileostomy. Colorectal Dis. 2009;11(8):866–871.
Sakai Y, Nelson H, Larson D, Maidl L, Young-Fadok T, Ilstrup D. Temporary
transverse colostomy vs loop ileostomy in diversion: a case-matched study. Arch Surg. 2001;136:338–342.
Salvadalena, G. Incidence of complications of the stoma and peristomal skin
among individuals with colostomy, ileostomy, and urostomy: a systematic review. J Wound Ostomy Continence Nurs. 2008;35(6):596–607.
Shabbir J, Britton DC. Stoma complications: a literature overview. Colorectal Dis.
2010;12:958.
Shemesh EI, Kodner IJ Statistics from the ostomy registry. Ostomy Quart.
1987;24:70.
Shirley F, Kodner IJ, Fry RD. Loop ileostomy: techniques and indications.
DisColon Rectum. 1984;27:382. Soliani P, Carbognani P, Piccolo P, Sabbagh R, Cudazzo E. Colostomy plug
devices: a possible new approach to the problem of incontinence. Dis Colon
Rectum. 1992;35:969. Stephenson ER Jr, Ilahi O, Koltun WA. Stoma creation through the stoma site:
a rapid, safe technique. Dis Colon Rectum. 1997;40:112–115. Svaninger G, Nordgren S, Palselius IR, Fasth S, Hulten L. Sodium and potas-
sium excretion in patients with ileostomies. Eur J Surg. 1991;157:601. Swain BT, Ellis CN Jr. Laparoscopy-assisted loop ileostomy: an acceptable
option for temporary fecal diversion after anorectal surgery. Dis Colon
Rectum. 2002;45:705–707. ompson JS, Williams SM. Technique for revision of continent ileostomy.
Dis Colon Rectum. 1992;35:87. Turnbull RB Jr, Weakley F, eds. Atlas of Intestinal Stomas. St. Louis, MO: CV
Mosby; 1967. Unti JA, Abcarian H, Pearl RK, et al. Rodless end-loop stomas: seven-year
experience. Dis Colon Rectum. 1991;34:999. Wexner SD, Taranow DA, Johansen OB, et al. Loop ileostomy is a safe option
for fecal diversion. Dis Colon Rectum. 1993;36:349. Wiesner RH, LaRusso NF, Dozois RR, Beaver SJ. Peristomal varices after proc-
tocolectomy in patients with primary sclerosing cholangitis. Gastroenterology.
1986;90:316. Winslet MC, Drolc Z, Allan A, Keighley MR. Assessment of the defunction-
ing eciency of the loop ileostomy. Dis Colon Rectum. 1991;34:699. Winslet MC, Poxon V, Youngs DJ, ompson H, Keighley MR. A patho-
physiologic study of diversion proctitis. Surg Gynecol Obstet. 1993;177:57. Young CJ, Eyers AA, Solomon MJ. Defunctioning of the anorectum: histori-
cal controlled study of laparoscopic vs. open procedures. Dis Colon Rectum.
1998;41: 190–194.
This page intentionally left blank

ABDOMINAL ABSCESS AND ENTERIC FISTULAE

Patrick S. Tawadros Jory Simpson Josef E. Fischer
• Ori D. Rotstein
10
ABDOMINAL ABSCESS
De nition and Etiology
Abscesses are well-de ned collections of infected purulent material that are walled o from the rest of the peritoneal cavity by in ammatory adhesions, loops of intestine and their mesentery, the greater omentum, or other abdominal viscera. Abscesses may occur in the peritoneal cavity, either within or outside of abdominal viscera (extravisceral), as well as in the retroperitoneum. abscesses that usually arise in one of two situations: (1)after res­olution of di use peritonitis in which a loculated area of infec­tion persists and evolves into an abscess and (2) after perforation of a viscus or an anastomotic breakdown that is successfully walled o by peritoneal defense mechanisms. More than 80% of intra-abdominal abscesses occur in the postoperative period, the majority of which occur after pancreaticobiliary or colorec­tal surgery and are usually related to anastomotic dehiscence. Occasionally, postsurgical abscesses result from infection of an intraperitoneal hematoma that develops following surgery. Less frequently, intra- abdominal abscesses are unassociated with previous surgery and are usually attributable to spontane­ous in ammatory processes associated with a small, localized perforation, such as in appendicitis, diverticulitis, and Crohn’s
3,
disease. hematogenous or lymphatic spread of bacteria to the organ. Retroperitoneal abscesses may be caused by several mecha­nisms, including perforation of the gastrointestinal (GI) tract into the retroperitoneum and hematogenous or lymphatic spread of bacteria to retroperitoneal organs, particularly the in amed pancreas.
4 Visceral abscesses are most commonly caused by
1
Most relevant to the surgeon are extravisceral
2,
3
Pathophysiology of Abscess Formation
After bacterial contamination of the peritoneal cavity, a complex series of events is initiated that, under ideal circum­stances, e ects complete eradication of invading bacteria.
 ethree major defense mechanisms in the peritoneal cavity are (1) mechanical clearance of bacteria via the diaphragmatic lymphatics, (2) phagocytosis and destruction of suspended or adherent bacteria by phagocytic cells, and (3) sequestration and walling o of bacteria coupled with delayed clearance by phagocytic cells. within hours. Egress of bacteria from the peritoneal cavity via the lymphatics is responsible for the early septic response due to bacteremia and initiation of the innate immune response to infection.
 e initial peritoneal response to bacterial contamina­tion is characterized by hyperemia, exudation of protein­rich  uid into the peritoneal cavity, and a marked in ux of phagocytic cells. Resident peritoneal macrophages pre­dominate early in the infection, but the rapid in ux of neutrophils after a 2- to 4-hour delay makes them the pre­dominant phagocytic cell in the peritoneal cavity for the  rst 48–72 hours. cells plus the in uxing into the peritoneum serves to propa­gate the initiation of the innate immune response, including the elaboration of in ammatory cytokines and the proco­agulant response. In humans with severe intra-abdominal infection, peritoneal levels of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1, and IL-6 are higher than lev­els measured simultaneously in plasma. leagues reported that TNF-α and IL-10 levels are increased and reach 100- to 1000-fold that is observed in the plasma following appendiceal perforation. In adult patients, a cor­relation between the magnitude of the cytokine response and outcome in infected patients has been demonstrated in several clinical studies. and IL-6 have been recorded in patients who later die with intra-abdominal infection. neal persist even after systemic in ammatory response has abated.  is suggests that during resolving peritonitis, there is compartmentalization of the response with local cytokine elaboration, thereby promoting local resolution of infec­tion. Other cell types are likely important in the initiation of the local peritoneal response. Peritoneal mast cells and
5
 e  rst two mechanisms act rapidly, usually
6
 e combination of resident peritoneal
7,
8 Haecker and col-
9
Higher levels of circulating TNF-α
7
Interestingly, elevated perito-
197
198 Part II Abdominal Wall
mesothelial lining cells have also been shown to be potent producers of a range of cytokines and procoagulants. Fibrin deposition appears to play an important role in this com­partmentalization of infection, not only by incorporating
10
large numbers of bacteria within its interstices
but also by causing loops of intestine to adhere to each other and the omentum, thereby creating a physical barrier against dissemination. Fibrin deposition is initiated after the exu­dation of protein-rich uid containing brinogen into the peritoneal cavity. e conversion of brinogen to brin is promoted by the elaboration of tissue factor by both mesothelial cells and stimulated peritoneal macrophages.
11
In addition, generation of other inammatory mediator molecules and components of the complement cascade (eg, C3a and C5a) further promotes the development of local inammation. e net eect of these responses is the local­ization of the bacterial infection in the peritoneal cavity, wherein ultimate resolution can occur. However, a number of local factors thwart complete resolution and presum­ably establish the local environment for persistent infection and hence abscess formation. ese include regional brin deposition that impedes phagocytic cell migration, factors that inhibit phagocytic cell function such as hemoglobin, particulate stool, low pH, and hypoxia. On the micro­bial side, polymicrobial ora of these infections as well as the near ubiquitous presence of Bacteroides fragilis and its unique capsular polysaccharide have been implicated in persistence of infection and abscess formation. Considered together, while the process of abscess formation represents a successful outcome of the peritoneal response to bacterial contamination of the peritoneal cavity, one is left with a residual infection that carries with it morbidity and poten­tial mortality and must be actively managed.
Clinical Presentation and Diagnosis
CLINICAL PRESENTATION
Diagnosis of an intra-abdominal abscess is based on clinical suspicion complemented by radiologic conrmation of the presence of the abscess. High spiking fevers, chills, tachycardia, tachypnea, and leukocytosis, associated with localized abdominal pain, anorexia, and delay in return of bowel function in the postoperative patient are the classic signs and symptoms associated with the presence of an intra­abdominal abscess. e presence of a well-localized tender mass on clinical examination is consistent with the presence of an abscess. However, there may be considerable variabil­ity in the clinical appearance of the patient with this infec­tion, ranging from a relatively mild picture where the patient appears generally well but is “slow to recover” from his surgi­cal procedure to those who manifest evidence of profound systemic inammation. ere may be no mass palpable on clinical examination. A number of factors may contribute to this variability, including patient factors such as age, immunocompetence, and concurrent use of antimicrobials,
aswellas abscess factors such location and size of the abscess and how well walled o the abscess is. For example, sub­phrenic abscesses can present with vague upper quadrant abdominal pain, referred shoulder pain, and occasionally hiccoughs but with no localized abdominal tenderness or palpable mass. By contrast, paracolic abscesses present with localized tenderness and may manifest as a palpable mass on abdominal examination. Pelvic abscesses may also cause local irritation of the urinary bladder causing frequency, or of the rectum resulting in diarrhea and tenesmus. Retroperitoneal collections, particularly psoas abscesses, can manifest as leg and back pain with muscular spasm and exion deformity of the hip. In reality, with the ready availability of computed tomography (CT) scanning in most institutions, almost any deviation from the normal recovery trajectory in the post­operative period will prompt a CT scan and possible early detection of the abscess.
DIAGNOSTIC TESTS
Imaging provides the denitive evidence of the presence of an intra-abdominal abscess. Abdominal plain lms can be help­ful in identifying air-uid levels in the upright or decubitus positions, extraluminal gas, or a soft tissue mass displacing the bowel. In the postoperative patient, however, extraluminal gas may be present for up to 7 days. Overall, plain radiography may suggest the presence of an abscess, but other imaging modalities have essentially replaced plain lms in the evalua­tion of intra-abdominal abscesses.
CT scanning has emerged as the radiological investigation of choice in the diagnosis of intra-abdominal abscess. its ready availability, it has essentially supplanted abdominal ultrasound (US) as the main diagnostic tool in this setting, mainly because of its accuracy, but also because its function­ality is not impaired in the setting of ileus, wound dressings, stomas, and the open abdomen. e accuracy of the scan is improved if contrast is used. IV contrast increases the accu­racy of dening the presence of an abscess, while GI tract contrast helps to distinguish uid-lled bowel loops from an abscess and in addition may detect the presence of an anas­tomotic leak. In a retrospective study that compared US and CT in diagnosing intra-abdominal abscesses, the sensitivity of US in 123 patients was 82% compared to 97% in 74 patients by CT, and the overall accuracy of US was found to be 90%
13
versus 96% for CT.
Criteria for identication of an abscess by CT have been well described and include identication of an area of low CT attenuation in an extraluminal location or within the parenchyma of solid abdominal organs. e density of abscesses usually falls between that of water and
14
solid tissue.
Other radiological signs of an abscess are mass eect that replaces or displaces normal anatomic structures, a lucent center that is not enhanced after the intravenous administration of a contrast medium, enhancing rim around the lucent center after IV contrast administration, and gas in the uid collection. One of the major advantages of CT over US is the ability to detect abscesses in the retroperito­neum and pancreatic area. ere are also some disadvantages
12
With
Chapter 10 Abdominal Abscess and Enteric Fistulae 199
to CTscanning. In the absence of contrast rim enhancement, gas or visible septations, CT cannot distinguish between ster­ile and infected  uid collections. Occasionally, there may be a solid-appearing collection that is really an abscess with a high leukocyte and protein content. Septations and other signs of loculated abscesses can often be better visualized with US than CT. Finally, CT scanning is sometimes unable to di er­entiate between subphrenic and pulmonic  uid, a relatively
15
common situation in abdominal surgery.
In these limited circumstances, US may be considered as a complement to CT imaging.
Other modalities include magnetic resonance imaging (MRI). While MRI can sometimes better delineate the extent of an abscess, particularly in relation to adjacent soft tissue structures such as muscles and major blood vessels, it does not clearly have advantages over CT scanning and its practicality
16
may be limited in the sick surgical patient.
One area where
US and MRI may be relevant is in the investigation of the
17
pregnant patient with abdominal pain.
US is particularly
useful when appendicitis/appendiceal abscess is suspected, and
of radiolabelled compounds in the diagnosis of abdominal
18
abscesses are limited at present.
Management
 e basic principles underlying the successful treatment of intra-abdominal abscesses are threefold:
1. Adequate resuscitation and support
2. Antimicrobial therapy
3. Source control/abscess drainage
ANTIMICROBIAL THERAPY
Considerations regarding antimicrobial use are based on the microbial  ora recovered from the infections. Over the past decade, there has been increasing appreciation that there is an evolution of the  ora with increasing severity of abdominal
20
infection.
For example, Table 10-1 shows the bacteriol­ogy of peritonitis in patients with community-acquired peritonitis and those with postoperative peritonitis.  e major pathogens in community-acquired intra-abdominal infections are coliforms (esp. Escherichia coli ) and anaerobes (esp. B. fragilis ). As illustrated, while both are polymicro- bial, postoperative peritonitis has a higher incidence of more resistant microbes. Aside from patients with postoperative peritonitis, other factors predict this shift in microbiology, including advanced age, severe physiologic derangement, immunosuppression, previous use of antibiotics, and resi­dence in a health care institution in hospitals and nursing homes, etc. Guidelines have been developed recently by the Surgical Infection Society and the Infectious Diseases Soci­ety of America regarding the use of antimicrobial therapy
21
in intra-abdominal infection.
 ese authors have risk­strati ed patients into three categories and provided recom­mendations for empiric antimicrobial regimens according to category.  e three categories are (1) community-acquired infections of mild to moderate severity; (2) high-risk or severe community-acquired infections; and (3) health care– associated infections. Factors that dictate conversion from mild-to-moderate severity to high severity include severe physiologic derangement (eg, high Acute Physiology and Chronic Health Evaluation II [APACHE II] score), advanced
RESUSCITATION AND SUPPORT
In keeping with the variable presentation of patients with intra-abdominal abscesses, the initial approach to resus­citation and support will vary considerably. Attention to the ABCs (airway, breathing, circulation) while individual­izing the intervention for each patient according to his/ her deviation from normal physiology is appropriate. Particularly in the postsurgical patient, nutritional sup­port should be considered. When feasible, oral nutrition should be given in preference to total parenteral nutrition. Some patients are able to ingest food and/or supplements by mouth, while others might require an enteral feeding tube, due to anorexia, precluding adequate ingestion of nutrients. Systematic review of the literature suggests that infectious complications and cost are reduced in critically ill patients receiving enteral nutrition compared to parenteral
19
nutrition.
One can presumably extrapolate to patients with intra-abdominal infection. When abscess formation occurs due to an anastomotic leak, there is a sense that this might preclude use of enteral nutrition.  is concern is likely unfounded, unless there is profound ileus associated with the infection.
TABLE 10-1: MICROBIOLOGY OF
COMMUNITY-ACQUIRED PERITONITIS COMPARED TO HEALTH CARE–ASSOCIATED PERITONITIS
Percent of Isolates of
Strain
Enterococci 5 21
Escherichia coli 36 19 Enterobacter sp 3 12 Bacteroides sp 10 7 Klebsiella sp 7 7 Staphylococcus aureus 1 6
Coagulase-negative staph 1 5
Candida 7 4 Pseudomonas sp 2 6
Streptococci 14 4 Hemolytic strep 3 0 Other 11 9
From Roehrborn A,  omas L, Potreck O, et al.  e microbiology of postoperative peritonitis. Clin Infect Dis . 2001;33:1513.
Community­Acquired
Postoperative (Health Care– Associated)
200 Part II Abdominal Wall
TABLE 10-2: RECOMMENDATIONS FOR ANTIMICROBIAL THERAPY
IN THE COMMUNITY-ACQUIRED SETTING
Community-Acquired Infection in Adults
Mild-to-Moderate Severity: Perforated or Abscessed Appendicitis and Other Infections of Mild-to­Moderate Severity
Regimen
Community-Acquired Infection in Pediatric Patients
High Risk or Severity: Severe Physiologic Disturbance, Advanced Age, or Immunocompromised State
Single agent Ertapenem, meropenem, imipenem-
cilastatin, ticarcillin-clavulanate, and piperacillin-tazobactam
Combination Ceftriaxone, cefotaxime, cefepime, or
ceftazidime, each in combination with metronidazole; gentamicin or tobramycin, each in combination with metronidazole or clindamycin, and with or without ampicillin
a Because of increasing resistance of Escherichia coli to  uoroquinolonoes, local population susceptibility pro les and, if available, isolate susceptibility should be reviewed. From Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133, with permission.
age, or immunocompromised state. Table 10-2 shows the recommended agents according to this strati cation.  ese guidelines are therefore readily applicable to decision making regarding patients coming into the hospital with abscesses, including processes such as appendiceal abscess or peridiverticular abscess. It is noteworthy that while entero­coccus is frequently recovered in isolates in these infections, the evidence demonstrates no additional bene t to treating this microbe as part of empiric therapy. When possible, swi­tchover to oral agents is appropriate.  e duration of anti­biotics should be 4–7 days, anticipating resolution of the clinical signs and symptoms during this period. Should there be no resolution by this time, reevaluation of the patient for the presence of persistent infection in the abdomen and else­where is appropriate.
Patients who present in the postsurgical period fall into the category of patients with health care–associated infection. In these patients, empiric therapy should include agents with expanded spectra against gram-negative aerobic and facultative bacilli, including meropenem, imipenem-cilastatin, doripenem, piperacillin-tazobactam, or ceftazidime or cefepime in combi­nation with metronidazole. Table 10-3 shows the considerations regarding selection depending on local institutional microbial isolates. Empiric anti-enterococcal treatment should be given. Treatment of Candida with  uconazole when recovered from cultures and treatment of methicillin-resistant Staphylococcus aureus with vancomycin should be followed if the patient is colonized with the microbe.
Cefoxitin, ertapenem, moxi oxacin, tigecycline, and ticarcillin-clavulanic acid Cefazolin, cefuroxime, ceftriaxone, cefotaxime, cipro oxacin, or levo ox acin, each in combination with metronidazole
a
discussion to abscess drainage, but adequate source control may also include debridement of necrotic tissue, surgical repair, resection, and/or exteriorization of the anatomic defect causing peritoneal contamination.
Over the past two decades, percutaneous drainage of abscesses has become an established technique and a safe alternative to surgery.  is evolution of care has not been based on a series of strong randomized trials showing equiv­alence or superiority of this approach. Rather, observational studies from a number of centers have shown it to be a safe e ective alternative to surgical intervention, with equiva­lent success rates, comparable mortality (10–20%) and morbidity (~25%). of percutaneous approaches including avoidance of general anesthesia, lower costs, and the potential for fewer compli­cations, it has now become the default approach to abscess management. Prerequisites for catheter drainage include an anatomically safe route to the abscess, a well-de ned uni­locular abscess cavity, concurring surgical and radiologic evaluation, and surgical backup for technical failure. Mul­tiple abscesses, abscesses with enteric connections as seen with enterocutaneous  stulas, and the need to traverse solid viscera are not contraindications. Indeed, as the technique has evolved over several decades, the barriers to accessing unusually positioned collections have disappeared with the use of unconventional routes (transgluteal, transvaginal, transrectal) and the advent of new technologies including
26,
endoscopic US.
27 Even the presence of septations and
Imipenem-cilastatin, meropenem, doripenem, and piperacillin-tazobactam
Cefepime, ceftazidime, cipro oxacin, or levo oxacin, each in combination with metronidazole
23–25
Combined with other advantages
a
22
loculations has not precluded at least an attempt to use per-
28
SOURCE CONTROL
Source control is a term used to include all physical measures taken to control a focus of infection. Here we focus our
cutaneous drainage.
Percutaneous drainage can be performed with US or CTguid­ance. CT provides for more precise identi cation of organsand bowel loops and is more accurate for planning of drainageroute.
15
Chapter 10 Abdominal Abscess and Enteric Fistulae 201
TABLE 10-3: RECOMMENDATIONS FOR ALTERATIONS IN ANTIMICROBIAL THERAPY IN
THE HEALTH CARE–ASSOCIATED SETTING
Regimen
Organisms Seen in Health Care–associated Infection at the Local Institution Carbapenem
<20% Resistant Pseudomonas aeruginosa, ESBL-producing
Enterobacteriaceae, Acneobacter, or other MDR GNB ESBL-producing Entorobacteriaceae
P. aeruginosa >20% resistant to ceftazidime MRSA Not recommended Not recommended Not recommended Not recommended Recommended
ESBL, extended-spectrum β-1actamase; GNB, gram-negative bacilli: MDR, multidrug resistant; MRSA, methicillin-resistant Staophylococcus aureus. NOTE . “Recommended” indicates that the listed agent or class is recommended for empiric use, before culture and susceptibility data are available, at institutions that encounter these isolates from other health care–associated infections.  ese may be unit-or hospital-speci c.
a
Imipenem-cilastatin, meropenem, or doripenem
Reproduced from Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis . 2010;50:133, with permission.
Recommended Recommended Recommemded Not recommended Not recommended
Recommended Recommended Not recommended Recommended Not recommended
Recommended Recommended Not recommended Recommended Not recommended
Piperacillin-
a
Tazobactam
Once the abscess is identi ed, initial diagnostic aspiration should be sent for Gram’s stain and microbiological culture.  e cath­eter used for drainage should be as small as possible for safety, yet large enough so that the tubing does not become obstructed. Most commonly used catheters range in size from 8 to 12F. With appropriate catheter placement, the abscess cavity typically decompresses and collapses. Irrigation of the catheter should be done once daily to ensure tube patency. As catheter drainage decreases, repeat CT scanning can be performed to evaluate for residual contents. If drainage increases over time or continues at a steady rate, the development of an enteric  stula must be sus­pected.  is may not have been unexpected when the catheter was initially placed near a perianastomotic abscess or an abscess adjacent to some underlying pathological process. Potential complications of catheter placement include bacteremia, sepsis, vascular injury, enteric puncture, cutaneous  stula, or transpleu­ral catheter placement.
Catheters should be maintained on closed drainage sys­tems.  ere does not appear to be bene t to the use of suction or irrigation of these catheters, although  ushing once per day with saline ensures patency. Patients should respond with defervesce of symptoms within 48 hours of catheter insertion. If they do so, a repeat CT scan is done at approximately 5–7 days to ensure shrinkage of the abscess. Criteria for removal of the drain include (1) clinical resolution of septic param­eters, including patient well-being, normal temperature, and leukocyte count; (2) minimal drainage from the catheter; and (3) CT evidence of the resolution of the absence.
As noted previously, studies comparing outcomes of sur­gical and percutaneous drainage of intra-abdominal abscesses
Ceftazidime or Cefepime, Each With Metronidazole Aminoglycoside Vancomycin
demonstrate comparable e cacy. In one study, patients were matched for age, abscess location, and etiology, and had similar APACHE II scores.  ere were no di erences between percu­taneous and surgical drainage in patient morbidity, mortality,
24
or duration of hospital stay.
Furthermore, initial percutane­ous drainage of abscesses in the context of diverticular disease allowed for subsequent de nitive operative resection and pri­mary anastomosis in one rather than two operations. Another group retrospectively examined postoperative intra-abdominal abscesses after laparotomy.  is study similarly demonstrated that use of either form of drainage resulted in similar cure rates
25
for postoperative intra- abdominal abscesses.
With clear demonstration of its e cacy when compared to surgical drainage, percutaneous drainage should be con­sidered the preferred approach in source control of abscesses. Table 10-4 shows outcome of percutaneous drainage accord­ing to underlying pathological processes. In general, one should predict a successful outcome in patients with a single, well-de ned abscess with no enteric communication.  e presence of enteric communication per se does not reduce the likelihood of success as it is de ned by the resolution of the infection. In a postoperative abscess, following drain­age of the infection, the underlying anastomotic defect will usually close. In other settings, there may be a requirement for subsequent surgery to manage the underlying disease process such as diverticular disease or Crohn’s disease. For example, in one study, approximately 75% of patients with large peridiverticular abscesses were drained percutaneously and then they went on to a single-stage sigmoid colectomy. Other circumstances such as fungal abscesses, infected
28